RE:What's next?co. continues to fly by the seat of its pants. Recall when co. announced results for 2% 1067 and shareholders thought the next step was commercialization. Then co. announces much later that it's testing 4% 1067, then 4% 1067 plus other formulations. So is this 1% anti-aging formula just the start of another iterative process with commercialization years away?
"We believe even more outstanding results are possible through planned modifications in our formulation and knowledge we have gained from this study."